OptimizeRx Corp
OPRX· Nasdaq
OPRXOptimizeRx Corp
Quarterly figures for OptimizeRx Corp, with source filings when available.
65 quarters. Jun 30, 2010 to Jun 30, 2026. USD.
OptimizeRx Corp has filed its 10-Q within 38 to 46 days of period end across its last 8 quarters. The 10-K runs 59 to 106 days.
OptimizeRx Corp · CIK 1448431 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 12, 2026 · after-hours | Aug 13, 2026 | 44 d | 10-Q | $20.50M | −29.8% | -$0.04 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 12, 2026 · after-hours |
| May 13, 2026 |
| 43 d |
| 10-Q |
| $19.84M |
| −9.5% |
| -$0.03 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 5, 2026 · after-hours | Mar 12, 2026 | 71 d | 10-K | $32.24M | −53.7% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 6, 2025 · after-hours | Nov 7, 2025 | 38 d | 10-Q | $26.07M | +22.3% | $0.04 | |
| Q2 2025 | Jun 30, 2025 | Aug 7, 2025 · after-hours | Aug 8, 2025 | 39 d | 10-Q | $29.20M | — | $0.08 | |
| Q1 2025 | Mar 31, 2025 | May 12, 2025 · after-hours | May 13, 2025 | 43 d | 10-Q | $21.93M | — | -$0.12 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 12, 2025 · market hours | Mar 20, 2025 | 79 d | 10-K | $69.60M | +145.3% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 13, 2024 · after-hours | Nov 14, 2024 | 45 d | 10-Q | $21.31M | +30.5% | -$0.50 | |
| Q2 2024 | Jun 30, 2024 | Aug 8, 2024 · after-hours | Aug 15, 2024 | 46 d | 10-Q | — | — | -$0.22 | |
| Q1 2024 | Mar 31, 2024 | May 14, 2024 · after-hours | May 15, 2024 | 45 d | 10-Q | — | — | -$0.38 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Mar 11, 2024 · after-hours | Apr 15, 2024 | 106 d | 10-K | $28.37M | — | — | |
| Q3 2023 | Sep 30, 2023 | Nov 6, 2023 · market hours | Nov 14, 2023 | 45 d | 10-Q | $16.33M | +8.3% | -$0.17 | |
| Q2 2023 | Jun 30, 2023 | Aug 14, 2023 · after-hours | Aug 14, 2023 | 45 d | 10-Q | $13.82M | −1.1% | -$0.24 | |
| Q1 2023 | Mar 31, 2023 | May 10, 2023 · after-hours | May 12, 2023 | 42 d | 10-Q | $13.00M | −5.3% | -$0.37 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 8, 2023 · after-hours | Mar 10, 2023 | 69 d | 10-K | — | — | — | |
| Q3 2022 | Sep 30, 2022 | Nov 8, 2022 · after-hours | Nov 8, 2022 | 39 d | 10-Q | $15.09M | −6.4% | -$0.19 | |
| Q2 2022 | Jun 30, 2022 | Aug 9, 2022 · after-hours | Aug 9, 2022 | 40 d | 10-Q | $13.98M | +2.6% | -$0.21 | |
| Q1 2022 | Mar 31, 2022 | May 4, 2022 · after-hours | May 9, 2022 | 39 d | 10-Q | $13.73M | +22.3% | -$0.21 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Feb 24, 2022 · after-hours | Feb 28, 2022 | 59 d | 10-K | — | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 9, 2021 | 40 d | 10-Q | $16.12M | +53.3% | $0.00 | |
| Q2 2021 | Jun 30, 2021 | Jul 27, 2021 · after-hours | Aug 4, 2021 | 35 d | 10-Q | $13.63M | +55.1% | $0.02 | |
| Q1 2021 | Mar 31, 2021 | Apr 28, 2021 · after-hours | May 6, 2021 | 36 d | 10-Q | $11.23M | +48.1% | -$0.04 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | Jan 25, 2021 · after-hours | Mar 8, 2021 | 67 d | 10-K | $16.43M | +122.6% | — | |
| Q3 2020 | Sep 30, 2020 | Oct 26, 2020 · after-hours | Nov 9, 2020 | 40 d | 10-Q | $10.52M | +110.3% | -$0.02 | |
| Q2 2020 | Jun 30, 2020 | Jul 23, 2020 · market hours | Aug 5, 2020 | 36 d | 10-Q | $8.78M | +25.4% | -$0.07 | |
| Q1 2020 | Mar 31, 2020 | May 5, 2020 · market hours | May 6, 2020 | 36 d | 10-Q | $7.58M | +45.6% | -$0.15 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Dec 31, 2019 | — | Mar 26, 2020 | 86 d | 10-K | $7.38M | +12.2% | — | |
| Q3 2019 | Sep 30, 2019 | — | Nov 5, 2019 | 36 d | 10-Q | $5.00M | −7.6% | -$0.11 | |
| Q2 2019 | Jun 30, 2019 | — | Aug 7, 2019 | 38 d | 10-Q | $7.01M | +37.4% | $0.03 | |
| Q1 2019 | Mar 31, 2019 | — | May 8, 2019 | 38 d | 10-Q | $5.21M | +26.7% | $0.00 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018derived | Dec 31, 2018 | — | Mar 12, 2019 | 71 d | 10-K | $6.58M | +64.2% | — | |
| Q3 2018 | Sep 30, 2018 | — | Nov 5, 2018 | 36 d | 10-Q | $5.42M | +74.5% | $0.02 | |
| Q2 2018 | Jun 30, 2018 | — | Aug 7, 2018 | 38 d | 10-Q | $5.10M | +77.9% | $0.02 | |
| Q1 2018 | Mar 31, 2018 | — | May 2, 2018 | 32 d | 10-Q | $4.11M | +91.1% | -$0.02 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017derived | Dec 31, 2017 | — | Mar 8, 2018 | 67 d | 10-K | $4.01M | +74.8% | — | |
| Q3 2017 | Sep 30, 2017 | — | Nov 2, 2017 | 33 d | 10-Q | $3.10M | +73.7% | -$0.06 | |
| Q2 2017 | Jun 30, 2017 | — | Aug 1, 2017 | 32 d | 10-Q | $2.87M | +49.8% | -$0.04 | |
| Q1 2017 | Mar 31, 2017 | — | May 3, 2017 | 33 d | 10-Q | $2.15M | +22.3% | -$0.03 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016derived | Dec 31, 2016 | — | Mar 8, 2017 | 67 d | 10-K | $2.29M | +13.5% | — | |
| Q3 2016 | Sep 30, 2016 | — | Nov 7, 2016 | 38 d | 10-Q | $1.79M | −11.0% | -$0.01 | |
| Q2 2016 | Jun 30, 2016 | — | Aug 8, 2016 | 39 d | 10-Q | $1.91M | +12.2% | — | |
| Q1 2016 | Mar 31, 2016 | — | May 9, 2016 | 39 d | 10-Q | $1.76M | +18.3% | -$0.01 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015derived | Dec 31, 2015 | — | Mar 15, 2016 | 75 d | 10-K | $2.02M | +2.7% | — | |
| Q3 2015 | Sep 30, 2015 | — | Nov 12, 2015 | 43 d | 10-Q | $2.01M | +10.3% | $0.00 | |
| Q2 2015 | Jun 30, 2015 | — | Aug 11, 2015 | 42 d | 10-Q | $1.71M | +19.5% | — | |
| Q1 2015 | Mar 31, 2015 | — | May 14, 2015 | 44 d | 10-Q | $1.49M | +15.4% | $0.00 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014derived | Dec 31, 2014 | — | Mar 31, 2015 | 90 d | 10-K | $1.97M | +57.8% | — | |
| Q3 2014 | Sep 30, 2014 | — | Nov 13, 2014 | 44 d | 10-Q | $1.82M | +48.5% | -$0.02 | |
| Q2 2014 | Jun 30, 2014 | — | Aug 14, 2014 | 45 d | 10-Q | $1.43M | +29.2% | — | |
| Q1 2014 | Mar 31, 2014 | — | May 15, 2014 | 45 d | 10-Q | $1.29M | +16.8% | -$0.04 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013derived | Dec 31, 2013 | — | Mar 31, 2014 | 90 d | 10-K | $1.25M | +80.3% | — | |
| Q3 2013 | Sep 30, 2013 | — | Nov 14, 2013 | 45 d | 10-Q | $1.23M | +170.4% | $0.00 | |
| Q2 2013 | Jun 30, 2013 | — | Aug 12, 2013 | 43 d | 10-Q | $1.10M | +114.2% | $0.01 | |
| Q1 2013 | Mar 31, 2013 | — | May 15, 2013 | 45 d | 10-Q | $1.10M | +235.2% | -$0.02 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012derived | Dec 31, 2012 | — | Mar 12, 2013 | 71 d | 10-K | $691.11K | +112.1% | — | |
| Q3 2012 | Sep 30, 2012 | — | Nov 14, 2012 | 45 d | 10-Q | $453.15K | +136.5% | -$0.01 | |
| Q2 2012 | Jun 30, 2012 | — | Aug 14, 2012 | 45 d | 10-Q | $515.42K | +157.5% | -$0.01 | |
| Q1 2012 | Mar 31, 2012 | — | May 15, 2012 | 45 d | 10-Q | $329.40K | −16.4% | — | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2011derived | Dec 31, 2011 | — | Mar 30, 2012 | 90 d | 10-K | $325.91K | — | — | |
| Q3 2011 | Sep 30, 2011 | — | Nov 14, 2011 | 45 d | 10-Q | $191.59K | +371.0% | — | |
| Q2 2011 | Jun 30, 2011 | — | Aug 17, 2011 | 48 d | 10-Q | $200.17K | +1,097.2% | — | |
| Q1 2011 | Mar 31, 2011 | — | May 16, 2011 | 46 d | 10-Q | $393.84K | — | — | |
| FY 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2010derived | Dec 31, 2010 | — | Mar 31, 2011 | 90 d | 10-K | — | — | — | |
| Q3 2010 | Sep 30, 2010 | — | Nov 16, 2010 | 47 d | 10-Q | $40.68K | — | — | |
| Q2 2010 | Jun 30, 2010 | — | Aug 16, 2010 | 47 d | 10-Q | $16.72K | — | — | |
